Anne‐Marie Martin
Eastern Health(AU)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Lung Cancer Treatments and Mutations, Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Phagocytosis and Immune Regulation
Most-Cited Works
- → Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma(2012)2,130 cited
- → Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma(2014)1,843 cited
- → Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL(2009)488 cited
- → Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer(2013)206 cited
- → Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials(2015)201 cited
- → Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436)(2013)183 cited
- → Concurrent MEK2 Mutation and BRAF Amplification Confer Resistance to BRAF and MEK Inhibitors in Melanoma(2013)180 cited
- → Screening for Genomic Rearrangements in Families with Breast and Ovarian Cancer Identifies BRCA1 Mutations Previously Missed by Conformation-Sensitive Gel Electrophoresis or Sequencing(2000)158 cited
- → Association of HPC2/ELAC2 Genotypes and Prostate Cancer(2000)158 cited
- → Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial(2020)97 cited